China Pharma Holdings (CPHI) Debt Ratio (2016 - 2025)
Historic Debt Ratio for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to 0.12.
- China Pharma Holdings' Debt Ratio fell 3250.21% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year decrease of 3250.21%. This contributed to the annual value of 0.17 for FY2024, which is 1020.77% up from last year.
- According to the latest figures from Q3 2025, China Pharma Holdings' Debt Ratio is 0.12, which was down 3250.21% from 0.2 recorded in Q2 2025.
- Over the past 5 years, China Pharma Holdings' Debt Ratio peaked at 0.24 during Q3 2021, and registered a low of 0.12 during Q3 2025.
- In the last 5 years, China Pharma Holdings' Debt Ratio had a median value of 0.17 in 2023 and averaged 0.17.
- As far as peak fluctuations go, China Pharma Holdings' Debt Ratio skyrocketed by 6152.39% in 2021, and later plummeted by 3250.21% in 2025.
- Quarter analysis of 5 years shows China Pharma Holdings' Debt Ratio stood at 0.19 in 2021, then fell by 28.19% to 0.14 in 2022, then increased by 12.62% to 0.15 in 2023, then increased by 10.21% to 0.17 in 2024, then fell by 27.35% to 0.12 in 2025.
- Its Debt Ratio was 0.12 in Q3 2025, compared to 0.2 in Q2 2025 and 0.18 in Q1 2025.